https://www.selleckchem.com/products/TGX-221.html
Treatment relies on non-steroidal anti-inflammatory drugs (NSAIDs) or low dose glucocortioids ( less then 20mg per day). Dose should be adjusted according to severity. The use of disease modifying anti-rheumatic drugs (DMARDs), either conventional and/or biological should be very cautious and result from a shared decision between oncologist and rheumatologist to best manage dysimmunitary complications without hampering the antitumor efficacy of ICI.The COVID-19 pandemic has a major impact at all stages of cancer treatment. Risk of death
Like
Comment
Share
